Improving viral vector safety for gene therapies
Drug Discovery World
AUGUST 21, 2024
The composition of engineered cells in vivo can change over time as clones proliferate at varying rates. Of acute concern are integrations that promote abnormal cell growth; while these may be exceedingly rare in the initial population, they can expand rapidly and develop into cancer. to 10% in hepatocytes.
59 
Let's personalize your content